Mass Spec
News on mass spectrometry technology and applications in genetics, genomics, and molecular diagnostics.
Fluidigm Obtains $250M Investment, Changing Name to Standard BioTools
The firm intends to simplify the design and execution of deep cell profiling, and standardize sample analysis with reproducible workflows and automation.
Virtue Diagnostics Raises $100M in Series B Financing
The firm is focused on providing clinical diagnostic products for early screening, initial diagnosis, treatment monitoring, and minimal residual disease management.
Copan Diagnostics Receives FDA 510(k) Clearance for Colibri Clinical Microbiology System
The system is intended for use with mass spectrometry microbiology platforms for automating the identification of Gram-negative and Gram-positive bacteria.
Elypta Expands Trial for Liquid Biopsy Kidney Cancer Recurrence Test; Plans Bladder Cancer Assay
Premium
Elypta is also developing a third test for the early detection of multiple cancers, which the company believes could eventually be used for routine cancer screening.
BioMark Diagnostics Nabs Canadian Funding for Lung Cancer Liquid Biopsy
The company is developing a metabolomic assay for early detection of lung cancer with academic collaborators at the University of Alberta.